{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/lipid-modification-cvd-prevention/how-this-topic-was-developed/search-strategy/","result":{"pageContext":{"chapter":{"id":"fbe34d96-9294-5a30-8de1-1bc1f631ce69","slug":"search-strategy","fullItemName":"Search strategy","depth":2,"htmlHeader":"<!-- begin field b174b1de-5078-44d3-bb4f-a7f2014cfefb --><h2>Search strategy</h2><!-- end field b174b1de-5078-44d3-bb4f-a7f2014cfefb -->","summary":null,"htmlStringContent":"<!-- begin item 0ee5bc5b-c2d3-4dfc-b8f4-a7f2014ba6a8 --><!-- begin field 4a38672a-7207-4f6c-8e3b-a7f2014cfefb --><h2>Scope of search</h2><!-- end field 4a38672a-7207-4f6c-8e3b-a7f2014cfefb --><!-- begin field 77fa503c-f1b1-41a1-b84b-a7f2014cfefb --><p>A literature search was conducted for guideline and systematic reviews on lipid modification for CVD prevention in primary care.</p><!-- end field 77fa503c-f1b1-41a1-b84b-a7f2014cfefb --><!-- begin field c8232e2b-25ed-4222-a60f-a7f2014cfefb --><h2>Search dates</h2><!-- end field c8232e2b-25ed-4222-a60f-a7f2014cfefb --><!-- begin field 17b065a7-5c6a-4d74-b753-a7f2014cfefb --><p>October 2014 - July 2019</p><!-- end field 17b065a7-5c6a-4d74-b753-a7f2014cfefb --><!-- begin field 685a32ea-d324-41a9-8cb6-a7f2014cfefb --><h2>Key search terms</h2><!-- end field 685a32ea-d324-41a9-8cb6-a7f2014cfefb --><!-- begin field 8aac0d68-92b8-4022-928f-a7f2014cfefb --><p>he terms listed below are the core search terms that were used for EBSCOhost MEDLINE (searched 19th July 2019). These were combined with filters to identify guidelines, systematic reviews and primary care relevant literature in EBSCOhost MEDLINE. The strategy was adapted for The Cochrane Library databases. </p><p>S9    S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 <br>S8    AB ( hypolidemic or hypolipidaemic ) OR TI ( hypolidemic or hypolipidaemic ) <br>S7    AB statin* OR TI statin* <br>S6    AB ( (hyperlipidaemia* or hyperlipidemia* or dyslipidaemia* or dyslipidemia* or hypercholesterolaema* or hypercholesterolemia* or hypertriglyceridaemia* or hypertriglyceridemia*) ) OR TI ( (hyperlipidaemia* or hyperlipidemia* or dyslipidaemia* or dyslipidemia* or hypercholesterolaema* or hypercholesterolemia* or hypertriglyceridaemia* or hypertriglyceridemia*) ) <br>S5    AB ( (lipid* N2 (lower* or modif* or management)) ) OR TI ( (lipid* N2 (lower* or modif* or management)) ) <br>S4    (MH \"Hydroxymethylglutaryl-CoA Reductase Inhibitors\") <br>S3    (MH \"Hypertriglyceridemia+\") <br>S2    (MH \"Hypercholesterolemia\") <br>S1    (MH \"Hyperlipidemias\") </p><!-- end field 8aac0d68-92b8-4022-928f-a7f2014cfefb --><!-- begin field 26db50d7-c993-41c1-ab59-a7f2014cfefb --><h2>Sources of guidelines</h2><!-- end field 26db50d7-c993-41c1-ab59-a7f2014cfefb --><!-- begin field a6b4f8a0-1ac9-41d0-8bc2-a7f2014cfefb --><ul><li><a href=\"https://www.nice.org.uk/\" data-hyperlink-id=\"9dfa68fd-eaa2-47a7-87d1-aa8700ee5612\">National Institute for Health and Care Excellence (NICE)</a></li><li><a href=\"https://www.sign.ac.uk/\" data-hyperlink-id=\"96ef65f6-7824-43b8-a4b0-aa8700ee5627\">Scottish Intercollegiate Guidelines Network (SIGN)</a></li><li><a href=\"https://www.rcplondon.ac.uk/\" data-hyperlink-id=\"b7de2894-ba4d-44d3-b69b-aa8700ee569e\">Royal College of Physicians</a></li><li><a href=\"https://www.rcgp.org.uk/\" data-hyperlink-id=\"a6ceb60d-fa15-49dd-90a7-aa8700ee56b7\">Royal College of General Practitioners</a></li><li><a href=\"https://www.rcn.org.uk/\" data-hyperlink-id=\"b8104206-5055-412d-915a-aa8700ee57de\">Royal College of Nursing</a></li><li><a href=\"https://www.evidence.nhs.uk/\" data-hyperlink-id=\"87ff45ca-a583-4602-bbe1-aa8700ee581e\">NICE Evidence</a></li><li><a href=\"https://www.who.int/\" data-hyperlink-id=\"5238871f-dde9-4bc1-b766-aa8700ee5833\">World Health Organization</a></li><li><a href=\"https://www.g-i-n.net/\" data-hyperlink-id=\"81b325b9-c134-4c45-af5f-aa8700ee583e\">Guidelines International Network</a></li><li><a href=\"http://www.tripdatabase.com/\" data-hyperlink-id=\"4d9275c3-802e-451f-bfa3-aa8700ee5861\">TRIP database</a></li><li><a href=\"https://www.ahrq.gov/\" data-hyperlink-id=\"c4af4541-ee4b-42c5-8401-aa8700ee5879\">Agency for Healthcare Research and Quality</a></li><li><a href=\"https://www.icsi.org/\" data-hyperlink-id=\"03d6f36e-3668-4454-b5db-aa8700ee5884\">Institute for Clinical Systems Improvement</a></li><li><a href=\"https://www.nhmrc.gov.au/research-policy\" data-hyperlink-id=\"c1761b02-d7f1-4677-ba5b-aa8700ee59fc\">National Health and Medical Research Council (Australia)</a></li><li><a href=\"https://www.racgp.org.au/clinical-resources/clinical-guidelines\" data-hyperlink-id=\"fc9f9bb8-a318-4b68-a6ad-aa8700ee5a08\">Royal Australian College of General Practitioners</a></li><li><a href=\"https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines\" data-hyperlink-id=\"5c02bfb6-c9df-4249-b22f-aa8700ee5cf9\">British Columbia Medical Association</a></li><li><a href=\"https://www.cma.ca/\" data-hyperlink-id=\"ea4b8af9-f0f2-4f73-be02-aa8700ee5d84\">Canadian Medical Association</a></li><li><a href=\"http://www.topalbertadoctors.org/cpgs/\" data-hyperlink-id=\"dd016267-198b-4a46-b716-aa8700ee5db2\">Alberta Medical Association</a></li><li><a href=\"http://mqic.org/guidelines.htm\" data-hyperlink-id=\"f092425c-e794-40fd-8df9-aa8700ee5e38\">Michigan Quality Improvement Consortium</a></li><li><a href=\"https://www.moh.gov.sg/resources-statistics\" data-hyperlink-id=\"380bafbe-007a-4587-825c-aa8700ee5e73\">Singapore Ministry of Health</a></li><li><a href=\"https://www.nric.org.uk/\" data-hyperlink-id=\"114c97a7-6e94-4cd6-8573-aa8700ee5e7e\">National Resource for Infection Control</a></li><li><a href=\"https://patient.info/patientplus\" data-hyperlink-id=\"a8212a11-5b3e-4e5d-a1c9-aa8700ee5e8c\">Patient UK Guideline links</a></li><li><a href=\"https://apps.nhslothian.scot/refhelp\" data-hyperlink-id=\"066b3066-f49d-4ae2-b7ac-aa8700ee5e99\">RefHELP NHS Lothian Referral Guidelines</a></li><li>Medline (with guideline filter)</li><li><a href=\"https://www.gov.uk/guidance/assessing-fitness-to-drive-a-guide-for-medical-professionals\" data-hyperlink-id=\"ea3e7313-2706-4cc4-8251-aa8700ee5ed0\">Driver and Vehicle Licensing Agency</a></li><li><a href=\"http://www.nhshealthatwork.co.uk/oh-guidelines.asp\" data-hyperlink-id=\"9d1a96fc-5b20-4f47-9c8c-aa8700ee5edb\">NHS Health at Work</a> (occupational health practice)</li></ul><!-- end field a6b4f8a0-1ac9-41d0-8bc2-a7f2014cfefb --><!-- begin field febb2fd9-1206-47b2-a856-a7f2014cfefb --><h2>Sources of systematic reviews and meta-analyses</h2><!-- end field febb2fd9-1206-47b2-a856-a7f2014cfefb --><!-- begin field 452cba15-3cfb-433b-a39a-a7f2014cfefb --><ul><li><a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"37327013-e788-4bfa-98f7-aa8700f8cdeb\">The Cochrane Library</a>:<ul><li>Systematic reviews</li><li>Protocols</li><li>Database of Abstracts of Reviews of Effects</li></ul></li><li>Medline (with systematic review filter)</li><li>EMBASE (with systematic review filter)</li></ul><!-- end field 452cba15-3cfb-433b-a39a-a7f2014cfefb --><!-- begin field a1905a80-bee7-4b50-b40c-a7f2014cfefb --><h2>Sources of health technology assessments and economic appraisals</h2><!-- end field a1905a80-bee7-4b50-b40c-a7f2014cfefb --><!-- begin field 46e5818c-34f6-4460-a1bf-a7f2014cfefb --><ul><li><a href=\"https://www.nihr.ac.uk/funding-and-support/funding-for-research-studies/funding-programmes/health-technology-assessment/\" data-hyperlink-id=\"3fafaa2c-6bc4-4f60-a1bf-aa8700fdcf96\">NIHR Health Technology Assessment programme</a></li><li><a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"064370b6-b5db-40a7-ab8c-aa8700fdd19a\">The Cochrane Library</a>:<ul><li>NHS Economic Evaluations</li><li>Health Technology Assessments</li></ul></li><li><a href=\"https://www.cadth.ca/\" data-hyperlink-id=\"6918a67d-6f2c-48b4-a039-aa8700fdd1e5\">Canadian Agency for Drugs and Technologies in Health</a></li><li><a href=\"http://www.inahta.org/\" data-hyperlink-id=\"e38eae99-ed4c-48dc-9066-aa8700fdd28c\">International Network of Agencies for Health Technology Assessment</a></li></ul><!-- end field 46e5818c-34f6-4460-a1bf-a7f2014cfefb --><!-- begin field 7cdf406d-ddf1-4b32-94cb-a7f2014cfefb --><h2>Sources of randomized controlled trials</h2><!-- end field 7cdf406d-ddf1-4b32-94cb-a7f2014cfefb --><!-- begin field 88adb948-95e6-481e-97ed-a7f2014cfefb --><ul><li><a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"913d7a6e-e37d-4940-896b-aa87010203d1\">The Cochrane Library</a>:<ul><li>Central Register of Controlled Trials</li></ul></li><li>Medline (with randomized controlled trial filter)</li><li>EMBASE (with randomized controlled trial filter)</li></ul><!-- end field 88adb948-95e6-481e-97ed-a7f2014cfefb --><!-- begin field 01adb3bc-8957-4d3c-8dc7-a7f2014cfefb --><h2>Sources of evidence based reviews and evidence summaries</h2><!-- end field 01adb3bc-8957-4d3c-8dc7-a7f2014cfefb --><!-- begin field 08f8c4a3-2a95-417a-af76-a7f2014cfefb --><ul><li><a href=\"http://www.bandolier.org.uk/\" data-hyperlink-id=\"7e314a9c-d64f-4fc3-a002-aa8701042b30\">Bandolier</a></li><li><a href=\"https://dtb.bmj.com/\" data-hyperlink-id=\"c1fdaed6-6d39-42fa-ad4c-aa8701042b3d\">Drug and Therapeutics Bulletin</a></li><li><a href=\"http://www.tripdatabase.com/\" data-hyperlink-id=\"5724cb24-099f-49fa-871b-aa8701042b47\">TRIP database</a></li><li><a href=\"http://www.medicinesni.com/index.asp\" data-hyperlink-id=\"c815a5bf-800f-4ad8-894b-aa8701042b5f\">Central Services Agency COMPASS Therapeutic Notes</a></li></ul><!-- end field 08f8c4a3-2a95-417a-af76-a7f2014cfefb --><!-- begin field e01e6696-cd95-40fc-8e39-a7f2014cfefb --><h2>Sources of national policy</h2><!-- end field e01e6696-cd95-40fc-8e39-a7f2014cfefb --><!-- begin field d0141181-a5f5-42bc-8797-a7f2014cfefb --><ul><li><a href=\"https://www.gov.uk/government/organisations/department-of-health-and-social-care\" data-hyperlink-id=\"921e1fa3-6850-4927-a626-aa870105524d\">Department of Health</a></li><li>Health Management Information Consortium (HMIC)</li></ul><!-- end field d0141181-a5f5-42bc-8797-a7f2014cfefb --><!-- begin field efb426a5-379c-4093-9413-a7f2014cfefb --><h2>Patient experiences</h2><!-- end field efb426a5-379c-4093-9413-a7f2014cfefb --><!-- begin field 68e3bbe5-555c-4399-962a-a7f2014cfefb --><ul><li><a href=\"https://healthtalk.org/\" data-hyperlink-id=\"b8ec4bf4-ded3-47a2-af31-aa8701067069\">Healthtalk</a></li><li><a href=\"https://www.bmj.com/specialties/patient-journeys\" data-hyperlink-id=\"f5ee8986-6b77-4f9a-b2ab-aa8701067076\">BMJ - Patient Journeys</a></li><li><a href=\"https://patient.info/health\" data-hyperlink-id=\"06629b71-260e-4c75-a393-aa8701067081\">Patient.co.uk - Patient Topics</a></li></ul><!-- end field 68e3bbe5-555c-4399-962a-a7f2014cfefb --><!-- begin field 3def77d1-0dcc-499d-9f48-a7f2014cfefb --><h2>Sources of medicines information</h2><!-- end field 3def77d1-0dcc-499d-9f48-a7f2014cfefb --><!-- begin field aa9d2b43-6440-4810-9f5d-a7f2014cfefb --><p>The following sources are used by CKS pharmacists and are not necessarily searched by CKS information specialists for all topics. Some of these resources are not freely available and require subscriptions to access content.</p><ul><li><a href=\"https://bnf.nice.org.uk/\" data-hyperlink-id=\"a497e5c5-2a40-411a-89e5-aa87010b0669\">British National Formulary</a> (BNF)</li><li><a href=\"https://www.medicines.org.uk/emc\" data-hyperlink-id=\"fc66c311-1da6-4ad6-b4e6-aa87010b067d\">electronic Medicines Compendium</a> (eMC)</li><li><a href=\"https://www.ema.europa.eu/en\" data-hyperlink-id=\"1f2bc3ca-e4c2-492e-a097-aa87010b06e0\">European Medicines Agency</a> (EMEA)</li><li><a href=\"https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm\" data-hyperlink-id=\"72b36e36-ead1-40d6-a7ec-aa87010b06f7\">LactMed</a></li><li><a href=\"https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency\" data-hyperlink-id=\"7da0f438-1f68-4356-80fb-aa87010b0748\">Medicines and Healthcare products Regulatory Agency</a> (MHRA)</li><li><a href=\"http://www.reprotox.org/\" data-hyperlink-id=\"ebbe343b-58d8-4802-b128-aa87010b0751\">REPROTOX</a></li><li><a href=\"https://www.scottishmedicines.org.uk/home\" data-hyperlink-id=\"ed27141d-0b95-40c2-99de-aa87010b07a4\">Scottish Medicines Consortium</a></li><li><a href=\"https://about.medicinescomplete.com/publication/stockleys-drug-interactions/\" data-hyperlink-id=\"b91b1e0e-b753-4c2f-934f-aa87010b07ea\">Stockley's Drug Interactions</a></li><li><a href=\"https://deohs.washington.edu/teris/\" data-hyperlink-id=\"da6ed978-7315-4e98-9ed6-aa87010b093e\">TERIS</a></li><li><a href=\"https://www.toxbase.org/\" data-hyperlink-id=\"b870e2fc-a63c-4ce7-abc4-aa87010b0995\">TOXBASE</a></li><li><a href=\"https://www.micromedexsolutions.com/home/dispatch\" data-hyperlink-id=\"df1fb482-0878-4583-bf42-aa87010b09a2\">Micromedex</a></li><li><a href=\"https://www.ukmi.nhs.uk/\" data-hyperlink-id=\"e53f7a80-d2a3-484f-a211-aa87010b0a37\">UK Medicines Information</a></li></ul><!-- end field aa9d2b43-6440-4810-9f5d-a7f2014cfefb --><!-- end item 0ee5bc5b-c2d3-4dfc-b8f4-a7f2014ba6a8 -->","topic":{"id":"5303951d-71d9-506d-84ec-cbdd7ff3b93e","topicId":"dc4f1ad8-1fac-4248-9071-a622ca58dd2c","topicName":"Lipid modification - CVD prevention","slug":"lipid-modification-cvd-prevention","lastRevised":"Last revised in October 2020","chapters":[{"id":"7834a360-a716-55db-beef-e74397381f6b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"4149ed5c-ad54-5793-8860-4b2f82d94427","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"184e9f02-cec5-5813-a428-f3b70683deda","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0fd087eb-ba58-59e6-b641-2161dd021687","slug":"changes","fullItemName":"Changes"},{"id":"6e535866-055b-5f94-8d43-67cc6c3262a6","slug":"update","fullItemName":"Update"}]},{"id":"6952071a-0b87-50ea-af6b-c7589b86f9bd","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"3de1ddbe-7a0f-5384-9939-9a56d2251dfc","slug":"goals","fullItemName":"Goals"},{"id":"1a8df6be-f747-5d74-81cf-54d938d5944b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"80c40530-2e39-55a1-910d-b5226d83d67a","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e9906a94-72bf-5a9e-8e05-bb7b6841fec3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"507f0f33-704f-5b79-813e-0ba2a367617e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c55b24f4-39a4-5919-8e05-5afc7b1ae5c6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f02326a5-5f6d-5026-9c8c-745fd760df23","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f4e4cb23-7f1d-5543-a7a5-9316a25c589b","slug":"lipids-cardiovascular-health","fullItemName":"Lipids and cardiovascular health"}]},{"id":"5123c607-afa6-5c07-a939-547efe27b94c","fullItemName":"Management","slug":"management","subChapters":[{"id":"ec817edb-2375-548c-beb5-8afb1596d294","slug":"lipid-therapy-primary-prevention-of-cvd","fullItemName":"Scenario: Lipid therapy - primary prevention of CVD"},{"id":"4cd90098-cba6-5b78-994c-9fc173b4fb3f","slug":"lipid-therapy-secondary-prevention-of-cvd","fullItemName":"Scenario: Lipid therapy - secondary prevention of CVD"}]},{"id":"35a2dc51-a5b3-56bd-9a02-c420e08c1d0d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"3e6af82a-f8f1-5d90-a988-05136fa101f3","slug":"statins","fullItemName":"Statins"}]},{"id":"238b503e-9352-5458-b356-3f6b521ef218","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"2dbe7113-fbe3-5fd2-bca1-2846dd9a39c8","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fbe34d96-9294-5a30-8de1-1bc1f631ce69","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"df527078-d479-5b6f-aff8-247af2cdd323","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1a8284ce-a2e5-59db-9d07-596f590c3ec3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9fe03c85-09a6-5232-8343-e77d91ad6145","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d5bce13d-7bb2-5366-8bcc-28f538824ee4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f5e3b9df-860b-5c62-a358-a408038abc28","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2dbe7113-fbe3-5fd2-bca1-2846dd9a39c8","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}